Published in Gynecol Oncol on March 17, 2009
Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options. World J Surg Oncol (2013) 0.90
Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis. Br J Cancer (2014) 0.83
Pelvic radiotherapy and sexual function in women. Transl Androl Urol (2015) 0.76
Patient-reported outcomes in sentinel lymph node procedure versus inguinofemoral lymphadenectomy: what is the next step? Gynecol Oncol (2009) 0.76
Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer. Br J Cancer (2013) 0.75
The impact of surgery for vulval cancer upon health-related quality of life and pelvic floor outcomes during the first year of treatment: a longitudinal, mixed methods study. Psychooncology (2015) 0.75
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer (2011) 3.45
New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis. Gynecol Oncol (2010) 2.27
Clinical implications of malnutrition in childhood cancer patients--infections and mortality. Support Care Cancer (2014) 2.07
Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale. Br J Gen Pract (1995) 1.86
Clinical risk factors as predictors of postmenopausal osteoporosis in general practice. Br J Gen Pract (2001) 1.73
Cancer, fatigue and the return of patients to work-a prospective cohort study. Eur J Cancer (2003) 1.71
[Summary of the Dutch College of General Practitioners' practice guideline 'Diagnosis of breast cancer']. Ned Tijdschr Geneeskd (2003) 1.71
The value of laboratory tests for the screening and recognition of alcohol abuse in primary care patients. J Fam Pract (1993) 1.57
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis. Br J Cancer (2009) 1.53
Tumour infiltration depth ≥4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol (2011) 1.48
Surveillance of women at high risk for hereditary ovarian cancer is inefficient. Br J Cancer (2006) 1.45
Mammography: interobserver variability in breast density assessment. Breast (2007) 1.44
Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers. Maturitas (2010) 1.43
Predicting postoperative mortality after colorectal surgery: a novel clinical model. Colorectal Dis (2014) 1.41
[Surgical treatment of early-stage vulva carcinoma and the complications of the operation]. Ned Tijdschr Geneeskd (2005) 1.41
Palliative resection of the primary tumour in stage IV rectal cancer. Colorectal Dis (2012) 1.40
Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol (2010) 1.38
The clinical trail of TRAIL. Eur J Cancer (2006) 1.35
Work ability and return-to-work in cancer patients. Br J Cancer (2008) 1.35
Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol (2006) 1.31
Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol (2011) 1.31
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study. Br J Cancer (2007) 1.30
A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer (2012) 1.28
Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol (2006) 1.24
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma. Histopathology (2007) 1.21
MEIS and PBX homeobox proteins in ovarian cancer. Eur J Cancer (2007) 1.19
Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol (2009) 1.16
The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy. Gynecol Oncol (2007) 1.15
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer. Br J Cancer (2008) 1.15
Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.10
Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol (2008) 1.09
The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma. BJOG (2009) 1.08
The whispered voice: the best test for screening for hearing impairment in general practice? Br J Gen Pract (1996) 1.08
Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study. Gynecol Oncol (2005) 1.08
The pattern of health care utilization of elderly people with arthritic pain in the hip or knee. Int J Qual Health Care (1997) 1.05
Health-related quality of life in patients with osteoarthritis in a family practice setting. Arthritis Care Res (1995) 1.03
Risk estimation for healthy women from breast cancer families: new insights and new strategies. Cancer Epidemiol Biomarkers Prev (2004) 1.02
Total pelvic exenteration for primary and recurrent malignancies. World J Surg (2009) 1.02
Results of a national survey among Dutch surgeons treating patients with colorectal carcinoma. Current opinion about follow-up, treatment of metastasis, and reasons to revise follow-up practice. Colorectal Dis (2007) 1.02
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies. Br J Cancer (2006) 1.01
Women's interest in GP-initiated pre-conception counselling in The Netherlands. Fam Pract (2003) 1.01
Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort. Gynecol Oncol (2007) 1.01
A quasi-randomised controlled trial of water as a quick softening agent of persistent earwax in general practice. Br J Gen Pract (2001) 1.01
Risk factors for short- and long-term complications after groin surgery in vulvar cancer. Br J Cancer (2011) 1.00
Management of vulvar cancers. Eur J Surg Oncol (2006) 0.99
Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion. J Chromatogr A (2003) 0.99
Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease. Int J Gynecol Cancer (2005) 0.96
Cortactin expression predicts poor survival in laryngeal carcinoma. Br J Cancer (2008) 0.95
Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy. Int J Gynecol Cancer (2006) 0.95
Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer. Br J Cancer (2010) 0.95
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands. Ann Oncol (2013) 0.95
Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study. Gynecol Oncol (2010) 0.94
Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis. J Chromatogr A (2006) 0.92
Lack of claudin-7 is a strong predictor of regional recurrence in oral and oropharyngeal squamous cell carcinoma. Oral Oncol (2013) 0.92
Numerous high-risk epithelial lesions in familial breast cancer. Eur J Cancer (2006) 0.92
Patterns of care in surgery for ovarian cancer in Europe. Eur J Surg Oncol (2010) 0.92
Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis. Br J Cancer (2011) 0.92
Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancer. Curr Cancer Drug Targets (2012) 0.91
"Cutaneous-type" angiosarcoma arising in a mature cystic teratoma of the ovary. J Clin Pathol (2006) 0.91
Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL. Br J Cancer (2013) 0.90
Prevalence of family histories of breast cancer in the general population and the incidence of related seeking of health care. J Med Genet (2003) 0.89
EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction. Gynecol Oncol (2006) 0.89
Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients. Br J Cancer (2000) 0.87
Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer. Eur J Cancer (2009) 0.87
HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients. Crit Rev Oncol Hematol (2012) 0.87
Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. Eur J Cancer (2013) 0.86
Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study. J Med Genet (2005) 0.86
Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia. J Clin Pathol (2003) 0.86
Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol (2011) 0.86
Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma. Oncology (2008) 0.86
A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer. Oncogene (2011) 0.85
The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited. Ann Oncol (2007) 0.85
Safety and cost-effectiveness of shortening hospital follow-up after breast cancer treatment. Br J Surg (2012) 0.85
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in 'pure' ductal carcinoma in situ of the breast. Histopathology (2007) 0.84
Value of the implantable doppler system in free flap monitoring. J Plast Reconstr Aesthet Surg (2012) 0.84
Microarray methods to identify factors determining breast cancer progression: potentials, limitations, and challenges. Crit Rev Oncol Hematol (2008) 0.84
Prediction of lymph node metastases in vulvar cancer: a review. Int J Gynecol Cancer (2006) 0.84
64 slice MDCT generally underestimates coronary calcium scores as compared to EBT: a phantom study. Med Phys (2007) 0.83
Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer. Gynecol Oncol (2002) 0.83
A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma. Gynecol Oncol (2005) 0.83
Genital psoriasis: a questionnaire-based survey on a concealed skin disease in the Netherlands. J Eur Acad Dermatol Venereol (2010) 0.83
Reliability of ultrasonography in detecting shoulder disease in patients with rheumatoid arthritis. Ann Rheum Dis (2008) 0.83
A phase I study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancer. Eur J Cancer (2005) 0.83
Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol Oncol (2009) 0.82
Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol (2004) 0.82
Impact of primary local treatment on the development of distant metastases or death through locoregional recurrence in young breast cancer patients. Breast Cancer Res Treat (2013) 0.82